China Medicine Corp.
Formerly Lounsberry Holdings III, Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2010 | $70 M | No. 1 | $50 to $250 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
China Medicine Corp. had revenue between $25 million and $100 million when it filed its newest notice of a funding round (Jun 2010).
SEC Form D (revenue range) · Jun 2010
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Jun 2010
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of China Medicine Corp. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Fred Cheung | Chief Financial Officer | Jun 2010 |
| Minhua Liu | Executive Vice President | Jun 2010 |
| Senshan Yang | Chief Executive Officer | Jun 2010 |
| Robert Lu | Executive officer | May 2010 |
| Daniel Shih | Director | Jun 2010 |
| Ian Grant Robinson | Director | Jun 2010 |
| Minhua Liu | Executive Vice President | Jun 2010 |
| Rachel Gong | Director | Jun 2010 |
| Ryan Shih | Director | Jun 2010 |
| Sean Shao | Director | Jun 2010 |
| Senshan Yang | Chief Executive Officer | Jun 2010 |
| Robert Adler | Director | May 2010 |
| Yangfang Chen | Director | May 2010 |